Search All News
New combination chemotherapies have improved survival for patients with pancreatic cancer, and oncologist Gulam Manji sees early signs that new treatments in trials may be even better.
Columbia researchers have identified a gene signature in localized prostate cancer that predicts the cancer’s odds of spreading and its response to a common treatment for advanced disease.
Immunotherapy, often ineffective against stomach cancer, was more effective when combined with chemotherapy and given earlier, finds a new study in mice.
Adam Bass, MD, will join the Herbert Irving Comprehensive Cancer Center as founding director of the Center for Precision Cancer Medicine and director of gastrointestinal oncology.
- April 5, 2018
3-D organoids created from the bladder cancers of patients mimic the characteristics of each patient’s tumor and may be used in the future to identify the best treatment for each patient.
- March 30, 2018
Though far from the most common form of cancer, brain cancers are uniquely difficult to treat. Columbia scientists are researching multiple new ways to attack the tumors.
- February 28, 2018
Pathology’s new recruit, Kevin Gardner, talks about health disparities and the need for more diversity among research participants.
- February 21, 2018
Two new precision medicine tests that look beyond cancer genes to identify novel therapeutic targets are now available to both oncologists and cancer researchers.
- February 12, 2018
A new optical imaging system developed at Columbia University uses red and near-infrared light to identify breast cancer patients who will respond best to chemotherapy.
- January 24, 2018
A mutation that leads to relapse in many leukemia patients also causes a weakness that could be exploited to kill the cancer cells, Columbia researchers have reported.
- January 18, 2018
Columbia researchers have identified two new breast cancer genes that also cause Lynch syndrome.
- January 11, 2018
A new study shows how stress accelerates pancreatic cancer development. Beta blockers, which block stress hormones, may increase survival for patients with the disease.
- January 3, 2018
The fusion of two adjacent genes can cause cancer by kicking mitochondria into overdrive and increasing the amount of fuel available for rampant cell growth.